UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 336

Sortiert nach

Covariate Pharmacokinetic Model Building in Oncology and its Potential Clinical Relevance

The AAPS journal, 2012-03, Vol.14 (1), p.119-132

Joerger, Markus

2012

Link zum Volltext

Verfügbarkeit prüfen

RAD51 as a potential surrogate marker for DNA repair capacity in solid malignancies

International journal of cancer, 2017-10, Vol.141 (7), p.1286-1294

2017

Link zum Volltext

Verfügbarkeit prüfen

Clinical importance of risk variants in the dihydropyrimidine dehydrogenase gene for the prediction of early‐onset fluoropyrimidine toxicity

International journal of cancer, 2015-02, Vol.136 (3), p.730-739

2015

Link zum Volltext

Verfügbarkeit prüfen

Predictive and Prognostic Value of DNA Damage Response Associated Kinases in Solid Tumors

Frontiers in oncology, 2020-11, Vol.10, p.581217-581217

2020

Link zum Volltext

Verfügbarkeit prüfen

Cancer chemotherapy: targeting folic acid synthesis

Cancer management and research, 2010-11, Vol.2 (default), p.293-301

2010

Link zum Volltext

Verfügbarkeit prüfen

Local tumor microbial signatures and response to checkpoint blockade in non-small cell lung cancer

Oncoimmunology, 2021-01, Vol.10 (1), p.1988403-1988403

2021

Link zum Volltext

Verfügbarkeit prüfen

Non-pharmaceutical interventions to optimize cancer immunotherapy

Oncoimmunology, 2023-12, Vol.12 (1), p.2255459-2255459

2023

Link zum Volltext

Verfügbarkeit prüfen

Vitamin C demand is increased after total knee arthroplasty: a double-blind placebo-controlled-randomized study

Knee surgery, sports traumatology, arthroscopy : official journal of the ESSKA, 2019-04, Vol.27 (4), p.1182-1188

2019

Link zum Volltext

Verfügbarkeit prüfen

Treatment regimens of classical and newer taxanes

Cancer Chemotherapy and Pharmacology, 2016-02, Vol.77 (2), p.221-233

Joerger, Markus

2016

Link zum Volltext

Verfügbarkeit prüfen

C reactive protein flare predicts response to checkpoint inhibitor treatment in non-small cell lung cancer

Journal for immunotherapy of cancer, 2022-03, Vol.10 (3), p.e004024

2022

Link zum Volltext

Verfügbarkeit prüfen

New antibody-drug conjugates (ADCs) in breast cancer—an overview of ADCs recently approved and in later stages of development

Exploration of targeted anti-tumor therapy, 2022-01, Vol.3 (1), p.27-36

2022

Link zum Volltext

Verfügbarkeit prüfen

24h-gene variation effect of combined bevacizumab/erlotinib in advanced non-squamous non-small cell lung cancer using exon array blood profiling

Journal of translational medicine, 2017-03, Vol.15 (1), p.66-66, Article 66

2017

Link zum Volltext

Verfügbarkeit prüfen

C-Reactive Protein as an Early Predictor of Efficacy in Advanced Non-Small-Cell Lung Cancer Patients: A Tumor Dynamics-Biomarker Modeling Framework

Cancers, 2023-11, Vol.15 (22), p.5429

2023

Link zum Volltext

Verfügbarkeit prüfen

Integrated Data Analysis of Six Clinical Studies Points Toward Model-Informed Precision Dosing of Tamoxifen

Frontiers in pharmacology, 2020-03, Vol.11, p.283

2020

Link zum Volltext

Verfügbarkeit prüfen

Randomized Phase II and Pharmacogenetic Study of Pemetrexed Compared With Pemetrexed Plus Carboplatin in Pretreated Patients With Advanced Non–Small-Cell Lung Cancer

Journal of clinical oncology, 2009-04, Vol.27 (12), p.2038-2045

2009

Link zum Volltext

Verfügbarkeit prüfen

A prognostic baseline blood biomarker and tumor growth kinetics integrated model in paclitaxel/platinum treated advanced non-small cell lung cancer patients

CPT: pharmacometrics and systems pharmacology, 2023-11, Vol.12 (11), p.1714-1725

2023

Link zum Volltext

Verfügbarkeit prüfen

Metabolism of the taxanes including nab-paclitaxel

Expert opinion on drug metabolism & toxicology, 2015-05, Vol.11 (5), p.691-702

Joerger, Markus

2015

Link zum Volltext

Verfügbarkeit prüfen

Circulating Deoxyribonucleic Acid As Prognostic Marker in Non–Small-Cell Lung Cancer Patients Undergoing Chemotherapy

Journal of clinical oncology, 2004-10, Vol.22 (20), p.4157-4164

2004

Link zum Volltext

Verfügbarkeit prüfen

Phase 1 first-in-human dose-escalation study of ANV419 in patients with relapsed/refractory advanced solid tumors

Journal for immunotherapy of cancer, 2023-11, Vol.11 (11), p.e007784

2023

Link zum Volltext

Verfügbarkeit prüfen

A prospective cohort study on the pharmacokinetics of nivolumab in metastatic non-small cell lung cancer, melanoma, and renal cell cancer patients

Journal for immunotherapy of cancer, 2019-07, Vol.7 (1), p.192-11, Article 192

2019

Link zum Volltext

Verfügbarkeit prüfen

Phase I/Ib, open-label, multicenter, dose-escalation study of the anti-TGF-β monoclonal antibody, NIS793, in combination with spartalizumab in adult patients with advanced tumors

Journal for immunotherapy of cancer, 2023-11, Vol.11 (11), p.e007353

2023

Link zum Volltext

Verfügbarkeit prüfen

Simulation-Based Assessment of the Impact of Non-Adherence on Endoxifen Target Attainment in Different Tamoxifen Dosing Strategies

Pharmaceuticals (Basel, Switzerland), 2021-02, Vol.14 (2), p.115

2021

Link zum Volltext

Verfügbarkeit prüfen

Computational Treatment Simulations to Assess the Need for Personalized Tamoxifen Dosing in Breast Cancer Patients of Different Biogeographical Groups

Cancers, 2021-05, Vol.13 (10), p.2432

2021

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 336

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(180)
Mit Volltextzugriff
(301)

Publikationsform

Sprache

Englisch
(191)
Deutsch
(151)
Japanisch
(12)

Erscheinungsjahr

n.n

Thema

Science & Technology
(126)
Life Sciences & Biomedicine
(124)
Humans
(98)
Oncology
(72)
Female
(55)
Male
(45)
Pharmacology & Pharmacy
(44)
Middle Aged
(42)
Grammar, Syntax, Linguistic Structure
(38)
Language & Linguistics
(38)
Usage & Grammar Guides
(38)
Aged
(36)
Adult
(35)
Pharmacokinetics
(27)
Tumors
(27)
Cancer
(26)
Patients
(26)
Chemotherapy
(23)
Prognosis
(23)
Carcinoma, Non-Small-Cell Lung - Drug Therapy
(21)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Covariate Pharmacokinetic Model Building in Oncology and its Potential Clinical Relevance

RAD51 as a potential surrogate marker for DNA repair capacity in solid malignancies

Clinical importance of risk variants in the dihydropyrimidine dehydrogenase gene for the prediction of early‐onset fluoropyrimidine toxicity

Predictive and Prognostic Value of DNA Damage Response Associated Kinases in Solid Tumors

Cancer chemotherapy: targeting folic acid synthesis

Local tumor microbial signatures and response to checkpoint blockade in non-small cell lung cancer

Non-pharmaceutical interventions to optimize cancer immunotherapy

Vitamin C demand is increased after total knee arthroplasty: a double-blind placebo-controlled-randomized study

Treatment regimens of classical and newer taxanes

C reactive protein flare predicts response to checkpoint inhibitor treatment in non-small cell lung cancer

New antibody-drug conjugates (ADCs) in breast cancer—an overview of ADCs recently approved and in later stages of development

24h-gene variation effect of combined bevacizumab/erlotinib in advanced non-squamous non-small cell lung cancer using exon array blood profiling

C-Reactive Protein as an Early Predictor of Efficacy in Advanced Non-Small-Cell Lung Cancer Patients: A Tumor Dynamics-Biomarker Modeling Framework

Integrated Data Analysis of Six Clinical Studies Points Toward Model-Informed Precision Dosing of Tamoxifen

Randomized Phase II and Pharmacogenetic Study of Pemetrexed Compared With Pemetrexed Plus Carboplatin in Pretreated Patients With Advanced Non–Small-Cell Lung Cancer

A prognostic baseline blood biomarker and tumor growth kinetics integrated model in paclitaxel/platinum treated advanced non-small cell lung cancer patients

Metabolism of the taxanes including nab-paclitaxel

Circulating Deoxyribonucleic Acid As Prognostic Marker in Non–Small-Cell Lung Cancer Patients Undergoing Chemotherapy

Phase 1 first-in-human dose-escalation study of ANV419 in patients with relapsed/refractory advanced solid tumors

A prospective cohort study on the pharmacokinetics of nivolumab in metastatic non-small cell lung cancer, melanoma, and renal cell cancer patients

Developing a Nationwide Infrastructure for Therapeutic Drug Monitoring of Targeted Oral Anticancer Drugs: The ON-TARGET Study Protocol

Phase I/Ib, open-label, multicenter, dose-escalation study of the anti-TGF-β monoclonal antibody, NIS793, in combination with spartalizumab in adult patients with advanced tumors

Simulation-Based Assessment of the Impact of Non-Adherence on Endoxifen Target Attainment in Different Tamoxifen Dosing Strategies

Outcome and Prognostic Factors of COVID-19 Infection in Swiss Cancer Patients: Final Results of SAKK 80/20 (CaSA)

Computational Treatment Simulations to Assess the Need for Personalized Tamoxifen Dosing in Breast Cancer Patients of Different Biogeographical Groups

Suchergebnisse filtern